ArticleCureus2026
A Curious Case of Intraductal Papillary Mucinous Neoplasm of the Bile Duct Presenting With Cholangitis.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Intraductal papillary mucinous neoplasm of the bile duct (IPMN-B) belongs to a group of biliary disorders that are premalignant lesions and have a relatively low incidence. We describe a case of a patient with IPMN-B who presented unusually with cholangitis and underwent surgical resection as a definitive treatment. The patient was a 65-year-old male who presented with a six-month history of recurrent right upper abdominal pain and loss of appetite, with a recent history of jaundice. Blood investigations showed leukocytosis with altered liver function test, with elevated bilirubin and liver enzymes. Ultrasound of the abdomen showed features suggestive of a cystic lesion in the left lobe of the liver. Further evaluation with a contrast MRI with magnetic resonance cholangiopancreatography (MRCP) showed a cystic lesion measuring 4x4 cm with mural lesions and biliary communication to the left hepatic duct. Serum CA19-9 was within normal limits (2 U/mL). Patient underwent endoscopic retrograde cholangiopancreatography (ERCP) in view of cholangitis and later had surgery in the form of left lateral sectionectomy with intraoperative cholangioscopy. The postoperative period was uneventful, and the patient was discharged on the fourth postoperative day. The histopathology report showed features suggestive of intraductal papillary mucinous neoplasm of the biliary tract with low-grade dysplasia. Patient was followed up at three months and was found to be without any complications. IPMN-B is a rare disease, and patients presenting with cholangitis are rather uncommon. Physicians need to be aware of such cases, as their management is different from cholangitis due to other causes, which are frequently encountered in clinical practice. IPMN-B requires a detailed imaging workup and definitive surgical resection due to its high risk of malignant transformation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.